IP Library Granted Patent US 7,634,126
Granted Patent B2
US 7,634,126 · App. 12/362,170 · Granted Dec 15, 2009

Blood and cell analysis using an imaging flow cytometer

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,634,126
App. No.
12/362,170
Granted
Dec 15, 2009
Kind
B2
Abstract

Multimodal/multispectral images of a population of cells are simultaneously collected. Photometric and/or morphometric features identifiable in the images are used to separate the population of cells into a plurality of subpopulations. Where the population of cells includes diseased cells and healthy cells, the images can be separated into a healthy subpopulation, and a diseased subpopulation. Where the population of cells does not include diseased cells, one or more ratios of different cell types in patients not having a disease condition can be compared to the corresponding ratios in patients having the disease condition, enabling the disease condition to be detected. For example, blood cells can be separated into different types based on their images, and an increase in the number of lymphocytes, a phenomenon associated with chronic lymphocytic leukemia, can readily be detected.

Claims (13)

1. An imaging system configured to acquire and analyze image data collected from a population of cells, where the image data include a plurality of images of individual cells that are acquired simultaneously, to enable a disease condition to be detected, comprising:

(a) a collection lens disposed so that light traveling from an individual cell passes through the collection lens and travels along a collection path;

(b) a light dispersing element disposed in the collection path so as to disperse the light that has passed through the collection lens into a plurality of light beams having different spectral content, thereby producing dispersed light;

(c) an imaging lens disposed to focus the dispersed light, producing focused dispersed light;

(d) a detector disposed to receive the focused dispersed light, such that the focused dispersed light incident on the detector simultaneously comprises a plurality of images of the individual cell, each of the plurality of images being formed from a different one of the plurality of light beam, the plurality of images comprising the image data; and

(e) a processor configured to analyze the image data for the plurality of images collected from individual cells in the population of cells, to determine if the image data indicate that the population of cells exhibit the disease condition.

2. The imaging system of claim 1 , further comprising:

(a) a laser light source that produces ultraviolet light; and

(b) optical elements configured to facilitate diffraction-limited imaging performance in the 400-460 nm spectral band.

3. The imaging system of claim 1 , wherein the processor is further configured to quantify an extent to which the disease condition is present.

4. The imaging system of claim 1 , wherein the plurality of images comprise at least one of the following two types of images:

(a) multispectral images; and

(b) multimodal images.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 27, 2023
From: LUMINEX CORPORATION; AMNIS, LLC; IRIS BIOTECH CORPORATION
To: CYTEK BIOSCIENCES, INC.
Reel/Frame 065044/0762 →
CHANGE OF NAME Recorded Feb 24, 2023
From: AMNIS CORPORATION
To: AMNIS, LLC
Reel/Frame 062917/0024 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 23, 2023
From: ORTYN, WILLIAM E.; BASIJI, DAVID A.; MORRISSEY, PHILIP; GEORGE, THADDEUS; HALL, BRIAN; ZIMMERMAN, CATHLEEN; PERRY, DAVID
To: AMNIS CORPORATION
Reel/Frame 062786/0521 →